Skip to the page

Data / Form D filings / Neela Therapeutics, Inc.

Neela Therapeutics, Inc.: Form D filings

Neela Therapeutics, Inc., a health care company in Lunenburg, MA, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on May 26, 2026, reports $13.8 million sold of a $21.5 million offering to 21 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
96 ROBBS HILL ROAD, Lunenburg, MA, 01462
Phone
(781) 929-6094
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2090797

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 26, 2026Amendment$21,510,000$13,821,643$7,688,35721Nov 14, 2025sec.gov
Nov 24, 2025New notice$13,510,000$12,010,000$1,500,00017Nov 14, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
PJ AnandExecutive Officer, Director
Norbert RiedelDirector
Richard UptonDirector
David DonabedianDirector
Edgar D. Jannotta Jr.Director
Stephen OesterleDirector

Other health care companies in Massachusetts that filed recently

Every Form D from the week of May 25, 2026 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Neela Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.